Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer-Reference-Cited by-同舟云学术

Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer

Published:2021-01-21 Issue:9 Volume:40 Page:1644-1658
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Abril Yashira L. Negrón^ORCID,Fernandez Irma R.,Hong Jun Young^ORCID,Chiang Ying-Ling^ORCID,Kutateladze Dennis A.,Zhao Qingjie,Yang Min,Hu Jing,Sadhukhan Sushabhan,Li Bo,He Bin,Remick Brenna,Bai Jessica Jingyi,Mullmann James,Wang Fangyu,Maymi Viviana,Dhawan Ravi,Auwerx Johan,Southard Teresa,Cerione Richard A.,Lin Hening^ORCID,Weiss Robert S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-020-01637-w.pdf

Reference52 articles.

1. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Prim. 2019;5:66.

2. Unterlass JE, Curtin NJ. Warburg and Krebs and related effects in cancer. Expert Rev Mol Med. 2019;21:e4.

3. Hirschey MD, Zhao Y. Metabolic regulation by lysine malonylation, succinylation, and glutarylation. Mol Cell Proteom: MCP. 2015;14:2308–15.

4. Lin H, Su X, He B. Protein lysine acylation and cysteine succination by intermediates of energy metabolism. ACS Chem Biol. 2012;7:947–60.

5. Bheda P, Jing H, Wolberger C, Lin H. The substrate specificity of sirtuins. Annu Rev Biochem. 2016;85:405–29.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation and inhibition of sirtuins: From bench to bedside;Medicinal Research Reviews;2024-08-31

2. Sirtuin 5 (SIRT5) Suppresses Tumor Growth by Regulating Mitochondrial Metabolism and Synaptic Remodeling in Gliomas;International Journal of Molecular Sciences;2024-08-22

3. New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery;Medicinal Chemistry Research;2024-06-08

4. Human SIRT5 variants with reduced stability and activity do not cause neuropathology in mice;iScience;2024-06

5. Non-oncogene dependencies: Novel opportunities for cancer therapy;Biochemical Pharmacology;2024-05